Tramadol for dogs — what owners should know

The short answer

Tramadol is an atypical opioid that produces analgesia partly through opioid receptor activity and partly through serotonin-norepinephrine reuptake inhibition. Effectiveness in dogs is variable, partly because the conversion to the active metabolite (M1) varies widely between individuals. As a single agent, modern guidelines deprioritise it; as part of a multimodal plan, it remains useful.

What the 2024 evidence changed

Several controlled trials in the late 2010s and early 2020s tested tramadol against placebo and against alternative analgesics for canine osteoarthritis and post-operative pain. Findings:

Tramadol monotherapy was no better than placebo for chronic osteoarthritis pain in some studies.
Inter-individual variability in plasma M1 concentration was very large.
Combination with NSAIDs and gabapentin produced better analgesia than any single agent.

The takeaway: tramadol works for some dogs, not for others, and reliable analgesia usually requires a combination approach.

When tramadol still has a place

NSAID-intolerant dogs. Older dogs with renal or hepatic compromise who cannot take long-term NSAIDs.
As an adjunct. Layered onto NSAID + gabapentin for chronic pain that is not fully controlled.
Short-term post-operative pain. A brief course as part of a multimodal protocol.
Cancer pain. Particularly in combination with bisphosphonates and gabapentin for bone-cancer pain.
Dogs who happen to be good responders. Some dogs visibly benefit from tramadol; if yours does, the evidence does not say to stop.

What may be better, depending on context

NSAIDs (carprofen, meloxicam, robenacoxib). First-line for inflammatory and arthritic pain in dogs without contraindications.
Gabapentin. Excellent for neuropathic pain, IVDD, post-surgical neuropathy.
Pregabalin. Newer alternative to gabapentin; less sedation in some dogs.
Amantadine. Adjunct for chronic refractory pain.
Buprenorphine, butorphanol. Opioid analgesia for short-term moderate-severe pain (vet-administered).
Bisphosphonates (pamidronate, zoledronate). Specific to bone-cancer pain.

Side effects to watch

Sedation, particularly in the first few days.
GI upset (nausea, vomiting, reduced appetite).
Constipation (less common than with classic opioids).
Rarely: seizures (in dogs with a seizure history; tramadol lowers the threshold).
Behavioural changes (restlessness or unusual quietness in some dogs).
Drug interactions — particularly with SSRI/SNRI antidepressants in the household; serotonin syndrome is rare but possible.

Why never share human tramadol

Dose ratios are different from human-by-weight scaling.
Some human formulations contain inactive ingredients unsuitable for dogs.
Tramadol is a controlled substance in many jurisdictions; legal exposure exists.
Without veterinary monitoring, side effects and interactions are not caught.

Common questions

My vet has prescribed tramadol — should I worry?

No. Tramadol is still useful in some contexts (mild-to-moderate pain in dogs who tolerate it well, particularly as an adjunct). The 2024 literature suggests it is less effective as monotherapy than once thought; it remains useful in combination.

Is tramadol addictive in dogs?

Dogs do not develop the same opioid-dependence patterns humans do. Long-term tramadol can produce GI side effects and rarely behavioural changes, but the addiction question that dominates human prescribing is not the main concern in dogs.

Can I give my dog my own tramadol?

No. Human tramadol formulations sometimes contain inactive ingredients (rarely xylitol; often unsuitable carriers) and the dose ratio differs from human-dose-by-weight. Always vet-prescribed for the specific dog.

Why does my friend's dog seem to do well on tramadol while mine does not?

Tramadol in dogs requires conversion to an active metabolite by an enzyme that varies between individual dogs. Some dogs are good metabolisers; others are poor. This explains the wide individual variation in response.

Editorial reference, not veterinary advice. — Dr. NRS, last reviewed 28 April 2026.